Cleveland Clinic tests gene therapy for cholesterol
Researchers at the Cleveland Clinic published results of the first human trial of the experimental drug CTX310. This drug may reduce levels of 'bad' cholesterol in the blood by half and has successfully completed the first phase of trials.
Covered by 1 of 6 media groups
- Budget not in the collected reports
- Public money not in the collected reports
- Media business 2 sources
- Big capital not in the collected reports
- Readers and grants not in the collected reports
- Undisclosed not in the collected reports
No newsrooms from these groups in the collected reports: budget, public money, big capital, readers and grants, undisclosed.
| Group | Share | Count |
|---|---|---|
Media business
| 100% | 2 items |
- Who the outlets write for
- community 0
- region 0
- country 2
- world 0
- Channels
- Websites 1
- Weeklies and analysis 1
- NVMedia business
- first item
- earliest
- national desk
Замість таблеток. Науковці Клівлендської клініки випробували на людях генну терапію проти холестерину
- Дзеркало тижняMedia businessCommentary
- first item
- caught up, 32 h later
- interpreters
Експериментальний препарат може удвічі зменшити рівень «поганого» холестерину в крові
Comments
Loading comments…